MRK vs VTRS
Merck (MRK) and Viatris (VTRS) compared side by side. Merck (MRK) is larger, with a market cap of $358.4B versus $20.7B for Viatris, about 17.3 times the size. VTRS returned +80.8% over the past year including dividends, versus +71.5% for MRK, through October 23, 2026..
Head to head
| Metric | MRK | VTRS |
|---|---|---|
| Market cap | $358.4B | $20.7B |
| P/E (TTM) | 117.2x | — |
| Forward P/E | 15.7x | 6.7x |
| Revenue (TTM) | $66.6B | $14.7B |
| Revenue growth | 5.1% | 4.9% |
| Gross margin | 75.9% | 40.3% |
| Operating margin | -0.2% | 12.6% |
| Free cash flow | $16.1B | $1.8B |
| Dividend yield | 2.34% | 2.67% |
| 1-year return | +71.5% | +80.8% |
| 5-year return (annual) | +15.8% | +9.8% |
| Max drawdown | -69% | -89% |
| FI Handbook grade | C | C- |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
$5.0K
$10.0K
$15.0K
$20.0K
20222023202420252026
MRK vs VTRS FAQ
Which is bigger, MRK or VTRS?
Merck (MRK) is larger, with a market cap of $358.4B versus $20.7B for Viatris, about 17.3 times the size.
Which stock performed better over the past year, MRK or VTRS?
VTRS returned +80.8% over the past year including dividends, versus +71.5% for MRK, through October 23, 2026.
Which pays a higher dividend, MRK or VTRS?
VTRS yields 2.67% versus 2.34% for MRK.